Piperazine → 1-(4-Methoxypyridin-2-yl)piperazine

HRID 270770

Reaktionsgleichung

Reaktionsgleichung von HRID 270770
Cl[C:2]1[CH:7]=[C:6]([O:8][CH3:9])[CH:5]=[CH:4][N:3]=1.[NH:10]1[CH2:15][CH2:14][NH:13][CH2:12][CH2:11]1>CN(C)C=O>[CH3:9][O:8][C:6]1[CH:5]=[CH:4][N:3]=[C:2]([N:10]2[CH2:15][CH2:14][NH:13][CH2:12][CH2:11]2)[CH:7]=1

Komponenten

4

Reaktionsbedingungen

Temperatur
115 °C

Versuchsvorschrift

To 756 mg (5.29 mmol) of 2-Chloro-4-methoxypyridine and 2.27 g (26 mmol) of piperazine in a pressure flask was added 2.7 mL dimethylformamide, and the mixture was heated at 115° C. for 5 hours. The solution was allowed to cool before opening the flask, and the resulting slurry was partitioned between ethyl acetate and water. The phases were separated, and the aqueous phase was back-extracted once with ethyl acetate. The combined ethyl acetate phases were washed once with brine, dried over Na2SO4, filtered, and the filtrate was acidified with 2M HCl in ether. The product crystallized over night, and the solids were isolated by filtration to yield product as a white solid: 1H NMR (D2O, 400 MHz) 7.72 (d, 1H), 6.61 (d, 1H), 6.48 (s, 1H), 3.88 (s, 3H), 3.79 (m, 4H), 3.36 (m, 4H) ppm.

Aufarbeitung

  1. temperatureto cool
  2. customthe resulting slurry was partitioned between ethyl acetate and water
  3. customThe phases were separated
  4. extractionthe aqueous phase was back-extracted once with ethyl acetate
  5. washThe combined ethyl acetate phases were washed once with brine
  6. dry with materialdried over Na2SO4
  7. filtrationfiltered
  8. customThe product crystallized over night
  9. customthe solids were isolated by filtration
  10. customto yield product as a white solid

Quellen und Nachweise

ORD-Eintrag
ord-7a4f4982e8e243fb84d125f179c1422b
Quelldatensatz
uspto-grants-2008_11
Patentnummer
US07449576B1

Verknüpfte Notizen

Wird geladen…